Supplementary Tables – Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care

Supplementary Table 1. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Patient socio-demographic and clinical characteristics at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Future Science Group, Figshare, Rodríguez, Albert Tuca, Viejo, Miguel Núñez, Maradey, Pablo, Canal-Sotelo, Jaume, Mancilla, Plácido Guardia, Rivero, Sonia Gutiérrez, Casillas, Inmaculada Raja, Abián, María Herrera, Bermudo, Cristina López
Format:	Dataset
Sprache:	eng
Schlagworte:	Cancer therapy (excl. chemotherapy and radiation therapy) Haematological tumours Solid tumours
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	Future Science Group, Figshare Rodríguez, Albert Tuca Viejo, Miguel Núñez Maradey, Pablo Canal-Sotelo, Jaume Mancilla, Plácido Guardia Rivero, Sonia Gutiérrez Casillas, Inmaculada Raja Abián, María Herrera Bermudo, Cristina López
description	Supplementary Table 1. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Patient socio-demographic and clinical characteristics at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 2. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Clinical features of background pain and BTcP at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP Supplementary Table 3. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Evolution of background pain and BTcP over the study period in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 4. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Quality of life outcomes according to the EORTC QLQ-C30 in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 5. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Global impression of improvement according to patient’s (PGI-I) and physician’s (CGI-I) perspective in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP.
doi_str_mv	10.25402/fon.19145240
format	Dataset
fullrecord	<record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_25402_fon_19145240</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_25402_fon_19145240</sourcerecordid><originalsourceid>FETCH-datacite_primary_10_25402_fon_191452403</originalsourceid><addsrcrecordid>eNqVz7FuwjAQxnEvDBUwdr8XgCZpGJhRqw4dkMpuXcKZnLjYru2AsrF35A15EtyqfYBOJ51-w_dX6rEsltWqLqon4-yyXJf1qqqLB_X1MXgv1JNNGEbYYSMU4Xa5wrs7w95Fgjg0wvYwoID5ZnYU4N4Hd8ryM785jeAMCBsCtuAxcXYRzpw6aALhMXXBDYcOWrQthSwywwRbFOGsTwQbDDRTE4MSaf57p2rx-rLbvC32mLDlRNoH7vNMXRb6J0bnGP0X8_xffwe_oltf</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Supplementary Tables – Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care</title><source>DataCite</source><creator>Future Science Group, Figshare ; Rodríguez, Albert Tuca ; Viejo, Miguel Núñez ; Maradey, Pablo ; Canal-Sotelo, Jaume ; Mancilla, Plácido Guardia ; Rivero, Sonia Gutiérrez ; Casillas, Inmaculada Raja ; Abián, María Herrera ; Bermudo, Cristina López</creator><creatorcontrib>Future Science Group, Figshare ; Rodríguez, Albert Tuca ; Viejo, Miguel Núñez ; Maradey, Pablo ; Canal-Sotelo, Jaume ; Mancilla, Plácido Guardia ; Rivero, Sonia Gutiérrez ; Casillas, Inmaculada Raja ; Abián, María Herrera ; Bermudo, Cristina López</creatorcontrib><description>Supplementary Table 1. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Patient socio-demographic and clinical characteristics at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 2. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Clinical features of background pain and BTcP at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP Supplementary Table 3. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Evolution of background pain and BTcP over the study period in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 4. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Quality of life outcomes according to the EORTC QLQ-C30 in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 5. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Global impression of improvement according to patient’s (PGI-I) and physician’s (CGI-I) perspective in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP.</description><identifier>DOI: 10.25402/fon.19145240</identifier><language>eng</language><publisher>Future Science Group</publisher><subject>Cancer therapy (excl. chemotherapy and radiation therapy) ; Haematological tumours ; Solid tumours</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>777,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.25402/fon.19145240$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Future Science Group, Figshare</creatorcontrib><creatorcontrib>Rodríguez, Albert Tuca</creatorcontrib><creatorcontrib>Viejo, Miguel Núñez</creatorcontrib><creatorcontrib>Maradey, Pablo</creatorcontrib><creatorcontrib>Canal-Sotelo, Jaume</creatorcontrib><creatorcontrib>Mancilla, Plácido Guardia</creatorcontrib><creatorcontrib>Rivero, Sonia Gutiérrez</creatorcontrib><creatorcontrib>Casillas, Inmaculada Raja</creatorcontrib><creatorcontrib>Abián, María Herrera</creatorcontrib><creatorcontrib>Bermudo, Cristina López</creatorcontrib><title>Supplementary Tables – Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care</title><description>Supplementary Table 1. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Patient socio-demographic and clinical characteristics at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 2. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Clinical features of background pain and BTcP at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP Supplementary Table 3. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Evolution of background pain and BTcP over the study period in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 4. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Quality of life outcomes according to the EORTC QLQ-C30 in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 5. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Global impression of improvement according to patient’s (PGI-I) and physician’s (CGI-I) perspective in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP.</description><subject>Cancer therapy (excl. chemotherapy and radiation therapy)</subject><subject>Haematological tumours</subject><subject>Solid tumours</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2022</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNqVz7FuwjAQxnEvDBUwdr8XgCZpGJhRqw4dkMpuXcKZnLjYru2AsrF35A15EtyqfYBOJ51-w_dX6rEsltWqLqon4-yyXJf1qqqLB_X1MXgv1JNNGEbYYSMU4Xa5wrs7w95Fgjg0wvYwoID5ZnYU4N4Hd8ryM785jeAMCBsCtuAxcXYRzpw6aALhMXXBDYcOWrQthSwywwRbFOGsTwQbDDRTE4MSaf57p2rx-rLbvC32mLDlRNoH7vNMXRb6J0bnGP0X8_xffwe_oltf</recordid><startdate>20220209</startdate><enddate>20220209</enddate><creator>Future Science Group, Figshare</creator><creator>Rodríguez, Albert Tuca</creator><creator>Viejo, Miguel Núñez</creator><creator>Maradey, Pablo</creator><creator>Canal-Sotelo, Jaume</creator><creator>Mancilla, Plácido Guardia</creator><creator>Rivero, Sonia Gutiérrez</creator><creator>Casillas, Inmaculada Raja</creator><creator>Abián, María Herrera</creator><creator>Bermudo, Cristina López</creator><general>Future Science Group</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20220209</creationdate><title>Supplementary Tables – Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care</title><author>Future Science Group, Figshare ; Rodríguez, Albert Tuca ; Viejo, Miguel Núñez ; Maradey, Pablo ; Canal-Sotelo, Jaume ; Mancilla, Plácido Guardia ; Rivero, Sonia Gutiérrez ; Casillas, Inmaculada Raja ; Abián, María Herrera ; Bermudo, Cristina López</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-datacite_primary_10_25402_fon_191452403</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cancer therapy (excl. chemotherapy and radiation therapy)</topic><topic>Haematological tumours</topic><topic>Solid tumours</topic><toplevel>online_resources</toplevel><creatorcontrib>Future Science Group, Figshare</creatorcontrib><creatorcontrib>Rodríguez, Albert Tuca</creatorcontrib><creatorcontrib>Viejo, Miguel Núñez</creatorcontrib><creatorcontrib>Maradey, Pablo</creatorcontrib><creatorcontrib>Canal-Sotelo, Jaume</creatorcontrib><creatorcontrib>Mancilla, Plácido Guardia</creatorcontrib><creatorcontrib>Rivero, Sonia Gutiérrez</creatorcontrib><creatorcontrib>Casillas, Inmaculada Raja</creatorcontrib><creatorcontrib>Abián, María Herrera</creatorcontrib><creatorcontrib>Bermudo, Cristina López</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Future Science Group, Figshare</au><au>Rodríguez, Albert Tuca</au><au>Viejo, Miguel Núñez</au><au>Maradey, Pablo</au><au>Canal-Sotelo, Jaume</au><au>Mancilla, Plácido Guardia</au><au>Rivero, Sonia Gutiérrez</au><au>Casillas, Inmaculada Raja</au><au>Abián, María Herrera</au><au>Bermudo, Cristina López</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Supplementary Tables – Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care</title><date>2022-02-09</date><risdate>2022</risdate><abstract>Supplementary Table 1. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Patient socio-demographic and clinical characteristics at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 2. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Clinical features of background pain and BTcP at baseline in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP Supplementary Table 3. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Evolution of background pain and BTcP over the study period in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 4. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Quality of life outcomes according to the EORTC QLQ-C30 in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP. Supplementary Table 5. Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care Global impression of improvement according to patient’s (PGI-I) and physician’s (CGI-I) perspective in the subpopulations treated with medium-to-high fentanyl doses (≥200μg) for BTcP.</abstract><pub>Future Science Group</pub><doi>10.25402/fon.19145240</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier	DOI: 10.25402/fon.19145240
ispartof
issn
language	eng
recordid	cdi_datacite_primary_10_25402_fon_19145240
source	DataCite
subjects	Cancer therapy (excl. chemotherapy and radiation therapy) Haematological tumours Solid tumours
title	Supplementary Tables – Low dose sublingual fentanyl improves quality of life in patients with breakthrough cancer pain at Palliative Care
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T01%3A03%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Future%20Science%20Group,%20Figshare&rft.date=2022-02-09&rft_id=info:doi/10.25402/fon.19145240&rft_dat=%3Cdatacite_PQ8%3E10_25402_fon_19145240%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true